Cargando…
Tumour budding and tumour–stroma ratio in hepatocellular carcinoma
BACKGROUND: Tumour budding and low tumour–stroma ratio (TSR) are associated with poor prognosis in some cancers, but their value in Western hepatocellular carcinoma is unclear. The prognostic value of tumour budding and TSR in hepatocellular carcinoma was examined. METHODS: Some 259 hepatocellular c...
Autores principales: | Kairaluoma, Valtteri, Kemi, Niko, Pohjanen, Vesa-Matti, Saarnio, Juha, Helminen, Olli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341881/ https://www.ncbi.nlm.nih.gov/pubmed/32362654 http://dx.doi.org/10.1038/s41416-020-0847-1 |
Ejemplares similares
-
Tumour-stroma ratio and prognosis in gastric
adenocarcinoma
por: Kemi, Niko, et al.
Publicado: (2018) -
Tumour-stroma ratio and 5-year mortality in gastric adenocarcinoma: a systematic review and meta-analysis
por: Kemi, Niko, et al.
Publicado: (2019) -
Does heterogeneity matter in the estimation of tumour budding and tumour stroma ratio in colon cancer?
por: Eriksen, Ann C., et al.
Publicado: (2018) -
Tumour-stroma ratio outperforms tumour budding as biomarker in colon cancer: a cohort study
por: Smit, Marloes A., et al.
Publicado: (2021) -
Author Correction: Tumour-stroma ratio and 5-year mortality in gastric adenocarcinoma: a systematic review and meta-analysis
por: Kemi, Niko, et al.
Publicado: (2020)